Bsx Stock — Buy Or Sell

: Many analysts, including those from Barclays and Goldman Sachs , see the current price (near its 52-week low of ~$59) as an attractive entry point with predicted upsides ranging from 37% to over 50%.

: Fresh data from the Heart Rhythm 2026 conference continues to support the safety and efficacy of key franchises like FARAPULSE and WATCHMAN . The Sell Case: Rising Risks bsx stock buy or sell

Data at Heart Rhythm 2026 highlight key Boston Scientific therapies : Many analysts, including those from Barclays and